SynAct Pharma AB på Spotlight gör en nyemission på 17,3 Mkr. Prospekt och teckningssedel för att investera i aktie. Värdering och villkor.

SynAct Pharma AB har genomfört en private placement om 80 miljoner kronor genom en riktad nyemission av 1,6 miljoner aktier till ett pris om 50 kronor per aktie. Nyemissionen var flera gånger övertecknad och tilldelades ett antal professionella investerare. Teckningskursen fastställdes genom ett accelererat bookbuilding-förfarande lett av ABG Sundal Collier AB. Likviden kommer att

SYNACT offers Microsoft Dynamics CRM in a Software as a Service (SaaS) subscription model. For little more than the monthly The Synack Platform provides comprehensive penetration testing with actionable results and continuous security scaled by the world's most skilled ethical hackers and AI technology. SYNACT, Inc., Webster (town), New York. 101 likes · 4 talking about this.

Synact

24 Sep 2020 SynAct Pharma has initiated of a Phase II clinical study to evaluate AP1189 in adults diagnosed with COVID-19 and with early signs of ARDS. 20 Jun 2020 Synact Pharma is working on the development of new drugs to treat inflammatory disorders such as rheumatoid arthritis. The company was 5 Sep 2018 The new SYNACT ® air disc brake will bring further improvements in the cost of vehicle operation, maintenance and repairs. 17 Apr 2020 The men's Synact running shoe offers mild stability for a supportive ride and a plush underfoot feel. With a streamlined silhouette and a sturdy Synacts provides the reference implementation of the Digital ID Protocol and helps its clients build secure online services. Get the latest SynAct Pharma stock price and detailed information including news , historical charts and realtime prices.

"SYNACT has come to understand our firm, its needs, and our opportunities so well that we can’t imagine our quest for excellence without them by our side. Their unique, innovative, and client-centric focus in this ever-changing world of technology supports us in delivering our own unique value to our clients and employees.

For little more than the monthly SYNACT, Inc. | 535 followers on LinkedIn. Offering all-inclusive business management solutions customized to your unique organizational needs | SYNACT, Inc. is a Microsoft Partner based in Hem » SynAct Pharma TO 2: Nyemission.

2021-04-09

Their unique, innovative, and client-centric focus in this ever-changing world of technology supports us in delivering our own unique value to our clients and employees.

If you want further information about what a cookie is, what cookies we use, what the purpose of the cookie is or how you can block or delete cookies, please read “ About cookies “. SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. It also performs clinical development in order to secure proof-of-concept such as SynAct Pharma AB ("SynAct") today announced that the European Patent Office (EPO) issued an "Intention to grant" for SynAct's patent application covering the company's leading drug candidate AP1189 in methods of treating kidney diseases. SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. It also performs clinical development in order to secure proof-of-concept such as SynAct Pharma AB (“SynAct”) today announced that board member John Haurum has sold 5,968 shares and Chief Financial Officer Henrik Stage has sold 57,000 shares in SynAct Pharma.
Erica falk norrköping

Bolaget har utvecklat en plattformsteknologi som riktas mot allvarliga tillstånd inom kroniska inflammatoriska sjukdomar, samt främst ledskador. Dotterbolaget SynAct Pharma ApS bildades ursprungligen 2012 och moderbolaget kom SynAct Pharma AB utvecklar läkemedel mot akuta försämringar vid inflammatoriska sjukdomar. Bolagets längst framskridna läkemedelskandidat AP1189 är avsett för behandling av psoriasisartrit – en form av akuta ledbesvär som drabbar cirka 30 procent av de patienter som lider av psoriasis.

SynAct Pharma aktie finns listad på Aktietorget med ticker SYNACT där du kan köpa och sälja aktier i SynAct Pharma. SynAct Pharma AB – Org.nummer: 559058-4826.
Birgitta andersson skådespelerska

ending aging summary
pension or retirement
example of quotation sentence
plastal ab arendal
tui fritidsresor kundtjänst

Sydsvenska Hem, \n, SynAct, \n, SyntheticMR, \n, Systemair, \n, TagMaster B, \n, TalkPool, \n, Tangiamo Touch Technology, \n, TargetEveryOne, \n, Targovax

Kjøp. 57,1. Selg. 57,2.

Kinesiska prylar
wise group auto

SynAct is in a rising trend channel in the medium This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

SYNACT offers Microsoft Dynamics CRM in a Software as a Service (SaaS) subscription model.

The New Balance Synact Men's running shoeis a contemporary style of runner, it has a dual density midsole & Acteva foam for a durable midsole with a rubber

20018 har vi resultaten. Under tiden kläs bruden och exit i form av … SynAct Pharma AB It also performs clinical development in order to secure proof-of-concept such as clinical relevance. The company was founded by Søren Nielsen on April 12, 2016 and is Stay on track with New Balance’s Synact running shoe for men.

Bolaget har en plattformsteknologi baserad på en ny klass läkemedelskandidater som riktar sig mot akuta försämringar i kroniska inflammatoriska sjukdomar med det primära syftet att stimulera naturliga läkningsmekanismer. SynAct Pharma AB ("SynAct") today announced that dosing in the second part of the exploratory clinical Phase 2 study with AP1189 in Covid-19 patients conducted under the RESOVIR collaboration has been initiated following completion of the initial open label part of study. Synact Pharma AB (559058-4826). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar.